Skip to main content
SpringerLink
Log in
Book cover

Hepatitis C Virus and Liver Transplantation pp 15–27Cite as

Donor–Recipient Matching in HCV-Infected Patients

  • Chapter
  • First Online:

Abstract

The current organ shortage scenario has prompted the increasing use of high-risk donor livers. These include livers from elderly donors, which have been convincingly shown to have an unfavorable impact on liver transplantation of hepatitis C virus (HCV)-infected patients. In addition, other donor-related risk factors include an unfavorable pattern of IL28B genotype, the donation after cardiac death (DCD), and the previous exposure of donors to hepatitis viruses. On the other hand, recipient-related risk factors in HCV-positive patients include ethnicity, female gender, again the pattern of IL28B genotype (CT or TT), and the presence of an HIV coinfection. Based on these data, the following recommendations can be made: First, grafts from donors aged > 70 years (in the Italian scenario) and, possibly, aged > 60 years (in other settings) should not be allocated to HCV-positive recipients. This policy is difficult, but can be implemented, and should be strongly encouraged, unless when it is plausible that it could lead to increased waiting list mortality. Second, great attention should be paid to donor–recipient matching in well-compensated HCV-positive recipients carrying hepatocellular carcinoma (HCC) within Milan criteria, in whom the final prognosis can be dramatically influenced by the age of the donor. If an elderly donor is being used, one should always carefully consider how to best balance the risk of dying/dropping out from the list because of HCC progression before liver transplantation (LT) and the risk of severe recurrence of HCV after LT. There are no data as yet to provide an evidence-based solution to this crucial issue, thus the decision should rely on a thorough and judicious clinical evaluation of both risks. Finally, some gender combinations may be deleterious in HCV-positive recipients and, accordingly, transplanting a male donor graft into a female recipient should be considered with caution, not only in the case of an elderly donor.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71.

    Article  PubMed  CAS  Google Scholar 

  2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.

    Article  PubMed  CAS  Google Scholar 

  3. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001;7:567–80.

    Article  PubMed  CAS  Google Scholar 

  4. Merion RM. Current status and future of liver transplantation. Semin Liver Dis. 2010;30:411–21.

    Article  PubMed  Google Scholar 

  5. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002;122:889.

    Article  PubMed  Google Scholar 

  6. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation. 2004;77:226–31.

    Article  PubMed  Google Scholar 

  7. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651–63.

    Article  PubMed  Google Scholar 

  8. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? Hepatology. 2006;45:484–8.

    Article  Google Scholar 

  9. Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, et al. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Digest Liver Dis. 2011;43:155–14.

    Article  Google Scholar 

  10. Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation. 2006;81:7–14.

    Article  PubMed  Google Scholar 

  11. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–90.

    Article  PubMed  CAS  Google Scholar 

  12. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post-transplant mortality for optimization of donor-recipient matching. Am J Transplant. 2009;9:318–26.

    Article  PubMed  CAS  Google Scholar 

  13. Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant. 2011;11:2724–36.

    Article  PubMed  CAS  Google Scholar 

  14. Berenguer M, Crippin J, Gish R, Bass N, Bostrom A, Netto G, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology. 2003;38:34–41.

    Article  PubMed  Google Scholar 

  15. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut. 2002;51:248–52.

    Article  PubMed  CAS  Google Scholar 

  16. Durand F, Renz JF, Alkofer B, Burra P, Clavien PA, Porte RJ, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008;14:1694–707.

    Article  PubMed  Google Scholar 

  17. Firpi RJ, Dong H, Clark VC, Soldevila-Pico C, Morelli G, Cabrera R, et al. IL28B in the donor CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant. Liver Int. 2013 Jan;33(1):72–8. doi:10.1111/liv.12013.

    Article  PubMed  CAS  Google Scholar 

  18. Ballarin R, Cucchetti A, Spaggiari M, Montalti R, Di Benedetto F, Nadalin S, et al. Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation. 2011;91:1265–72.

    Article  PubMed  Google Scholar 

  19. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci. 2005;9:295–7.

    PubMed  CAS  Google Scholar 

  20. Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, et al. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. J Hepatol. 2013;58(4):715–23. pii: S0168-8278(12)00894-X. doi:10.1016/j.jhep.2012.11.025.

    Article  PubMed  Google Scholar 

  21. Tao R, Ruppert K, Cruz RJ Jr, Malik SM, Shaikh O, Ahmad J, et al. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts. Liver Transpl. 2010;6:1288–95.

    Article  Google Scholar 

  22. Layden JE, Cotler S, Brown KA, Lucey MR, Te HS, Eswaran S, et al. Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation. 2012;94:178–84.

    Article  PubMed  Google Scholar 

  23. Poynard T, Bedossa P, Opolon P, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;49:825–32.

    Article  Google Scholar 

  24. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450–6.

    Article  PubMed  CAS  Google Scholar 

  25. Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Camma C, et al. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl. 2007;13:733–40.

    Article  PubMed  Google Scholar 

  26. Lai JC, Verna EC, Brown RS Jr, O’Leary JG, Trotter JF, Forman LM, et al. Hepatitis C virus-infected women have high risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology. 2011;54:418–24.

    Article  PubMed  Google Scholar 

  27. Graziadei IW, Zoller HM, Schloegl A, Nachbaur K, Pfeiffer KP, Mark W, et al. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation. Liver Transpl. 2012;18:671–9.

    Article  PubMed  Google Scholar 

  28. Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C infection. Hepatology. 2011;53:317–24.

    Article  PubMed  CAS  Google Scholar 

  29. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012;18:716–26.

    Article  PubMed  Google Scholar 

  30. Bosch W, Heckman MG, Pungpapong S, Diehl NN, Shalev JA, Hellinger WC. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation. Transplantation. 2012;93:723–8.

    Article  PubMed  Google Scholar 

  31. Angelico M, Marianelli T, Ginanni Corradini S, Gavrila C, Miglioresi L, Sforza D, Ettorre GM, Gerunda GM, Rossi M, Tisone G, Nardi M. The use of cytomegalovirus (CMV)-negative donors older than 60 years is selectively associated with poor post-transplantation outcomes in CMV-positive recipients: an age-related cause of latent CMV reactivation? J Hepatol. 2013 (EASL abstract).

    Google Scholar 

  32. Lai JC, Feng S, Roberts JP, Terrault NA. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant. 2011;11:296–302.

    Article  PubMed  CAS  Google Scholar 

  33. Romagnoli R, Rossi M, Gerunda GE, Pinna A, Agnes S, Tisone G, et al. Graft survival is significantly worst in HCV-infected liver transplanted females receiving an organ from male donors: results from the Liver Match study. Liver Transpl. 2012 (ILTS abstract).

    Google Scholar 

Download references

Acknowledgment

The authors wish to thank Prof. Alessandra Nardi and Dr. Caius Gavrila for providing the figures and the updated results of the Liver Match Study.

Author information

Authors and Affiliations

  1. Hepatology and Liver Transplantation Unit, Department of Experimental Medicine and Surgery, Tor Vergata University, 00133, Rome, Italy

    Prof. Mario Angelico M.D. & Ilaria Lenci M.D., Ph.D.

Authors
  1. Prof. Mario Angelico M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilaria Lenci M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Angelico M.D. .

Editor information

Editors and Affiliations

  1. La Fe Hospital, University of Valencia and Ciberehd, Valencia, Spain

    Marina Berenguer

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Angelico, M., Lenci, I. (2014). Donor–Recipient Matching in HCV-Infected Patients. In: Berenguer, M. (eds) Hepatitis C Virus and Liver Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8438-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8438-7_2

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8437-0

  • Online ISBN: 978-1-4614-8438-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation